High-performance liquid chromatography screening reveals HbS/β+-thalassemia double heterozygosity as a pediatric muscular dystrophy mimic
Laboratory Medicine · 03.04.2026 · 57 (3)
DOI: 10.1093/labmed/lmag019 ↗Kurz gefasst
Fallbericht in der Zeitschrift Laboratory Medicine, online erschienen am 22.04.2026. Verfasst von Carlos López-Medina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Analysis Unit, Biotechnology Department, Poniente University Hospital, El Ejido, Almería, Spain. Hauptthemen laut MEDLINE: beta-Thalassemia, Muscular Dystrophies, Hemoglobin, Sickle. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Compound hemoglobinopathies may present with variable clinical phenotypes, particularly when additional genetic modifiers coexist. Sickle cell hemoglobin (HbS)/β+-thalassemia can mimic other pediatric conditions, potentially delaying diagnosis. High-performance liquid chromatography (HPLC) is a widely accessible first-line screening tool that can facilitate identification of HbS/β+-thalassemia.
Methods
An 8-year-old boy from Mali presented with recurrent severe lower limb pain and gait impairment, initially suggesting a neuromuscular disorder. Laboratory evaluation revealed severe microcytic hypochromic anemia (hemoglobin, 6.3 g/dL) with reticulocytosis and biochemical evidence of hemolysis, despite preserved iron stores. Creatine kinase levels were normal. Peripheral smear showed anisopoikilocytosis with target cells, basophilic stippling, and rare sickled erythrocytes.
Results
The HPLC findings demonstrated HbS predominance (64.2%) with elevated fetal hemoglobin (8.1%), increased adult hemoglobin A2 (5.4%), and residual adult hemoglobin A (22.3%), consistent with HbS/β+-thalassemia. Molecular testing confirmed heterozygous HbS and β+-thalassemia variants, homozygous 3.7-kilobase α-globin gene deletion, and a pathogenic glucose-6-phosphate dehydrogenase A‒ haplotype. Positive parvovirus B19 immunoglobulin M suggested an additional acute trigger.
Discussion
Routine hematologic parameters combined with HPLC screening can promptly identify complex hemoglobinopathies in clinically misleading presentations, enabling accurate diagnosis, appropriate management, and genetic counseling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Analysis Unit, Biotechnology Department, Poniente University Hospital, El Ejido, Almería, Spain.
- Pediatric Department, Poniente University Hospital, El Ejido, Almería, Spain.
- Haematology and Haemotherapy Department, Torrecárdenas University Hospital, Almería, Spain.
- Haematology and Haemotherapy Unit, Biotechnology Department, Poniente University Hospital, El Ejido, Almería, Spain.
ORCID-Profile: Maria-Angustias Molina-Arrebola
Zitieren
APA
López-Medina, C., Portell-Rigo, I. M., González-Iribarren, V., González-Oller, C., Sánchez-Crespo, A., & Molina-Arrebola, M. A. (2026). High-performance liquid chromatography screening reveals HbS/β+-thalassemia double heterozygosity as a pediatric muscular dystrophy mimic. Laboratory Medicine, 57(3). https://doi.org/10.1093/labmed/lmag019
Vancouver
López-Medina C, Portell-Rigo IM, González-Iribarren V, González-Oller C, Sánchez-Crespo A, Molina-Arrebola MA. High-performance liquid chromatography screening reveals HbS/β+-thalassemia double heterozygosity as a pediatric muscular dystrophy mimic. Laboratory Medicine. 2026;57(3). doi:10.1093/labmed/lmag019
BibTeX
@article{LpezMedina2026,
author = {López-Medina, Carlos and Portell-Rigo, Isabel M and González-Iribarren, Virginia and González-Oller, Carlos and Sánchez-Crespo, Alicia and Molina-Arrebola, Maria-Angustias},
title = {High-performance liquid chromatography screening reveals HbS/β+-thalassemia double heterozygosity as a pediatric muscular dystrophy mimic},
journal = {Laboratory Medicine},
year = {2026},
volume = {57},
number = {3},
doi = {10.1093/labmed/lmag019}
}
EUVIMED